05/15/2025
11:31 AM | Beryl Capital Management LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/21/2025
7:00 AM | Marinus Pharmaceuticals (Filer)
| Form 15-12G | |
02/14/2025
3:30 PM | Marinus Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
11:15 PM | Marinus Pharmaceuticals (Filer)
| Form EFFECT | |
02/13/2025
11:15 PM | Marinus Pharmaceuticals (Filer)
| Form EFFECT | |
02/13/2025
11:15 PM | Marinus Pharmaceuticals (Filer)
| Form EFFECT | |
02/12/2025
5:40 PM | Marinus Pharmaceuticals (Subject)
Sofinnova Investments, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
02/11/2025
7:45 PM | Marinus Pharmaceuticals (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G | |
02/11/2025
7:20 PM | Marinus Pharmaceuticals (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/11/2025
10:08 AM | FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
7:53 AM | Marinus Pharmaceuticals (Filer)
| Form S-8 POS | |
Get the Latest News and Ratings for MRNS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Marinus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/11/2025
7:53 AM | Marinus Pharmaceuticals (Filer)
| Form S-8 POS | |
02/11/2025
7:54 AM | Marinus Pharmaceuticals (Filer)
| Form S-8 POS | |
02/11/2025
7:54 AM | Marinus Pharmaceuticals (Filer)
| Form S-8 POS | |
02/11/2025
7:54 AM | Marinus Pharmaceuticals (Filer)
| Form S-8 POS | |
02/11/2025
7:54 AM | Marinus Pharmaceuticals (Filer)
| Form S-8 POS | |
02/11/2025
7:55 AM | Marinus Pharmaceuticals (Filer)
| Form S-8 POS | |
02/11/2025
7:55 AM | Marinus Pharmaceuticals (Filer)
| Form S-8 POS | |
02/11/2025
8:05 AM | Marinus Pharmaceuticals (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
02/11/2025
8:10 AM | Marinus Pharmaceuticals (Issuer)
Silverstein Christine Berni (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:11 AM | Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:12 AM | Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:13 AM | Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:14 AM | Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:16 AM | MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:17 AM | Johnson Marvin (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:18 AM | Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:19 AM | Fischer Seth H. Z. (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:19 AM | Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
7:49 AM | Marinus Pharmaceuticals (Filer)
| Form POS AM | |
02/11/2025
7:41 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2025
7:48 AM | Marinus Pharmaceuticals (Filer)
| Form POS AM | |
02/11/2025
7:49 AM | Marinus Pharmaceuticals (Filer)
| Form POS AM | |
02/07/2025
6:01 AM | Immedica Pharma AB (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC TO-T/A | |
02/07/2025
6:10 AM | Marinus Pharmaceuticals (Subject)
| Form SC 14D9/A | |
02/04/2025
1:13 PM | Marinus Pharmaceuticals (Subject)
MORGAN STANLEY (Filed by)
| Form SCHEDULE 13G | |
01/31/2025
11:14 AM | Marinus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/29/2025
4:17 PM | Immedica Pharma AB (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC TO-T/A | |
01/29/2025
3:44 PM | Marinus Pharmaceuticals (Subject)
| Form SC 14D9/A | |
01/23/2025
3:16 PM | Johnson Marvin (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:17 PM | Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
What 99% of investors are missing about Chinese AI (Ad) Chinese AI chatbot DeepSeek's release put the spotlight on AI and turned the tech world on its head.
But 99% of investors likely missed one key detail.
One projected to be worth trillions in the near future.
Nvidia CEO Jensen Huang even highlighted it in his most recent earnings call. Investors might unwittingly be making a mistake that could impact their portfolios. |
01/08/2025
3:41 PM | Immedica Pharma AB (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC TO-T | |
01/07/2025
6:15 PM | Beryl Capital Management LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
01/02/2025
2:25 PM | Immedica Pharma AB (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC TO-C | |
12/30/2024
6:11 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
6:11 AM | Marinus Pharmaceuticals (Subject)
| Form SC14D9C | |
12/30/2024
6:00 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
3:02 PM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
2:18 PM | Marinus Pharmaceuticals (Subject)
Nochur Sara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
9:35 AM | Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G/A | |
11/15/2024
7:00 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:39 PM | Marinus Pharmaceuticals (Subject)
Sofinnova Investments, Inc. (Filed by)
| Form SC 13G | |
11/14/2024
2:04 PM | Cormorant Asset Management, LP (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024
11:24 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024
8:34 AM | Avoro Capital Advisors LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/12/2024
8:55 AM | JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/01/2024
7:30 PM | Marinus Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
| Form SC 13G | |
10/31/2024
12:05 PM | FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
10/24/2024
7:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
6:57 AM | Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
6:56 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
7:15 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:00 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
6:09 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
3:27 PM | Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:27 PM | Marinus Pharmaceuticals (Issuer)
Silverstein Christine Berni (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:20 PM | Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:21 PM | Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:21 PM | Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:21 PM | MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:22 PM | Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:23 PM | Austin Charles (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:23 PM | Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy MRNS Stock Free MRNS Stock Alerts